PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET

被引：7

作者：

Dong, Hongmei ^{[1
,2
,3
,4
]}

Lin, Wan ^{[5
]}

Du, Liang ^{[6
]}

Yao, Zhimeng ^{[1
,2
,3
,7
]}

Li, Feifei ^{[8
]}

Chen, Shuanglong ^{[1
,2
,3
]}

Huang, Yiteng ^{[9
]}

Ren, Hongzheng ^{[10
,11
]}

Luo, Yichen ^{[1
,2
,3
]}

Cai, Songwang ^{[12
]}

Chen, Yexi ^{[13
]}

Tang, Hui ^{[14
,15
]}

Qiu, Xiaofu ^{[16
]}

Pan, Yunlong ^{[4
]}

Huang, Xingxu ^{[17
]}

Zhang, Dianzheng ^{[18
]}

Gao, Shegan ^{[19
,23
]}

Yeung, Sai-Ching Jim ^{[20
,21
,24
]}

Zhang, Hao ^{[4
,22
]}

机构：

[1] Jinan Univ, Inst Precis Canc Med & Pathol, Guangzhou, Peoples R China

[2] Jinan Univ, Sch Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China

[3] Jinan Univ, Minister Educ, Key Lab Tumor Mol Biol, Guangzhou, Guangdong, Peoples R China

[4] Jinan Univ, Dept Gen Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[5] Shantou Univ, Canc Res Ctr, Med Coll, Shantou, Guangdong, Peoples R China

[6] Chongqing Univ, Canc Hosp, Radiat Oncol Ctr, Chongqing, Peoples R China

[7] Jinan Univ, Affiliated Hosp 1, Dept Urol Surg, Guangzhou, Guangdong, Peoples R China

[8] Peoples Hosp Leshan, Dept Oncol, Leshan, Sichuan, Peoples R China

[9] Shantou Univ, Hlth Care Ctr, Affiliated Hosp 1, Med Coll, Shantou, Guangdong, Peoples R China

[10] Naval Med Univ, Gongli Hosp, Dept Pathol, Shanghai, Peoples R China

[11] Changzhi Med Coll, Dept Pathol, Heping Hosp, Changzhi, Shanxi, Peoples R China

[12] Jinan Univ, Dept Thorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[13] Shantou Univ, Dept Gen Surg, Affiliated Hosp 2, Med Coll, Shantou, Guangdong, Peoples R China

[14] Jinan Univ, Dept Cent Lab, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[15] Jinan Univ, Heyuan Shenhe Peoples Hosp, Dept Clin Lab, Affiliated Hosp 5, Heyuan, Peoples R China

[16] Guangdong Second Prov Gen Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China

[17] Nanjing Univ, Model Anim Res Ctr, MOE, Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China

[18] Philadelphia Coll Osteopath Med, Dept Biomed Sci, Philadelphia, PA USA

[19] Henan Univ Sci & Technol, Coll Clin Med, Affiliated Hosp 1, Henan Key Lab Canc Epigenet, Luoyang 471003, Henan, Peoples R China

[20] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX USA

[21] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX USA

[22] Jinan Univ, Dept Gen Surg, Affiliated Hosp 1, 613 Huangpu Ave West, Guangzhou 510630, Guangdong, Peoples R China

[23] Henan Univ Sci & Technol, Coll Clin Med, Affiliated Hosp 1, Henan Key Lab Canc Epigenet, Luoyang 471003, Henan, Peoples R China

[24] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA

来源：

CANCER LETTERS | 2023年 / 567卷

关键词：

PTPRO; Tyrosine phosphatase; MET; Esophageal squamous cell carcinoma; Metastasis; RECEPTOR-TYROSINE KINASE; C-MET; GENE AMPLIFICATION; LUNG-CANCER; CELL; EGFR; CARCINOGENESIS; METHYLATION; RESISTANCE; MODEL;

D O I：

10.1016/j.canlet.2023.216283

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Protein tyrosine phosphatase receptor-type O (PTPRO) is a membrane-bound tyrosine phosphatase. Notably, epigenetically silenced PTPRO due to promoter hypermethylation is frequently linked to malignancies. In this study, we used cellular and animal models, and patient samples to demonstrate that PTPRO can suppress the metastasis of esophageal squamous cell carcinoma (ESCC). Mechanistically, PTPRO can inhibit MET-mediated metastasis by dephosphorylating Y1234/1235 in the kinase activation loop of MET. Patients with PTPROlow/ p-METhigh had significantly poor prognosis, suggesting that PTPROlow/p-METhigh can serve as an independent prognostic factor for patients with ESCC.

引用

页数：10

共 50 条

[41] Possible biomarkers for predicting lymph node metastasis of esophageal squamous cell carcinoma: a review
Li, Juan
Qi, Zhan
Hu, Yuan-Ping
Wang, Yu-Xiang
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (02) : 544 - 556
[42] A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma
Xiaofeng Duan
Xiaobin Shang
Jie Yue
Zhao Ma
Chuangui Chen
Peng Tang
Hongjing Jiang
Zhentao Yu
BMC Cancer, 21
[43] Clinicopathologic Factors Predicting Lymph Node Metastasis in Superficial Esophageal Squamous Cell Carcinoma
Lee, Hyun Jeong
Kim, Gwang Ha
Lee, Bong Eun
Baek, Dong Hoon
Song, Geun Am
GASTROENTEROLOGY, 2014, 146 (05) : S511 - S511
[44] Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis
Araki, K
Ohno, S
Egashira, A
Saeki, H
Kawaguchi, H
Sugimachi, K
CANCER, 2002, 94 (02) : 570 - 575
[45] Abdominal Lymph Node Metastasis in Patients with Mid Thoracic Esophageal Squamous Cell Carcinoma
Gang Chen
Zhou Wang
Xiang-yan Liu
Ming-yue Zhang
Fan-ying Liu
World Journal of Surgery, 2009, 33 : 278 - 283
[46] PTTG Overexpression Promotes Lymph Node Metastasis in Human Esophageal Squamous Cell Carcinoma
Yan, Shuang
Zhou, Cuiqi
Lou, Xiaomin
Xiao, Zefen
Zhu, Hongxia
Wang, Qifeng
Wang, Yihua
Lu, Ning
He, Shun
Zhan, Qimin
Liu, Siqi
Xu, Ningzhi
CANCER RESEARCH, 2009, 69 (08) : 3283 - 3290
[47] Abdominal Lymph Node Metastasis in Patients with Mid Thoracic Esophageal Squamous Cell Carcinoma
Chen, Gang
Wang, Zhou
Liu, Xiang-Yan
Zhang, Ming-Yue
Liu, Fan-Ying
WORLD JOURNAL OF SURGERY, 2009, 33 (02) : 278 - 283
[48] ASO Author Reflections: Supraclavicular Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma
Seong Yong Park
Junghee Lee
Yeong Jeong Jeon
Jong Ho Cho
Hong Kwan Kim
Yong Soo Choi
Jae Il Zo
Young Mog Shim
Annals of Surgical Oncology, 2024, 31 : 1583 - 1584
[49] Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy
Hamai, Yoichi
Emi, Manabu
Ibuki, Yuta
Kurokawa, Tomoaki
Yoshikawa, Toru
Ohsawa, Manato
Hirohata, Ryosuke
Murakami, Yuji
Nishibuchi, Ikuno
Imano, Nobuki
Nagata, Yasushi
Okada, Morihito
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1798 - 1807
[50] A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma
Duan, Xiaofeng
Shang, Xiaobin
Yue, Jie
Ma, Zhao
Chen, Chuangui
Tang, Peng
Jiang, Hongjing
Yu, Zhentao
BMC CANCER, 2021, 21 (01)

← 1 2 3 4 5 →